The pros and cons of buying Challenger shares this month

Could this be the right time to look at the annuity king?

| More on:
Two people comparing and analysing material.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Challenger Ltd (ASX: CGF) share price jumped 6.5% yesterday after reporting its FY24 result. Investors loved the ASX financial share's report which showed good growth. After such good numbers, it's worth asking if the annuity provider is a buy.

A business can still be good value even if it goes up in price because the reported numbers may have demonstrated that the current share price still doesn't reflect how good the outlook truly is.

The business reported a number of positives, which may bode well for FY25 (and beyond).

Let's run through some of the highlights before considering if it's a buy.

Positive result recap

The company reported that it generated normalised net profit before tax (NPBT) of $608 million, up 17%.

Challenger's group assets under management (AUM) grew by 21% to $127 billion, partly thanks to life sales of $9.1 billion, with lifetime annuity sales of $1.5 billion (up 110%).

Normalised earnings per share (EPS) grew by 14% to 60.9 cents per share. The normalised return on equity (ROE) was 15.6%, up 290 basis points (2.90%) – Challenger said it's on track to achieve its ROE target in FY25. The ROE target is the RBA cash rate plus a margin of 12%.

The board of Challenger decided to lift the full-year dividend by 10% to 26.5 cents per share.

However, the company did report that its statutory net profit after tax (NPAT) declined 24% to $130 million. This number included the unrealised impact of lower commercial property valuations and changes to the UK mortality rate assumptions.

The broker UBS said that earnings beat market expectations and were ahead of the guidance range, and the dividend was stronger than expected, which helped the Challenger share price rise. However, the statutory net profit was "surprisingly low due to very large investment experience loss". Despite that, the balance sheet strength improved.

UBS suggested there were some question marks on the company's capital position.  

Is the Challenger share price a buy?

The outlook for the business seems positive, in my opinion, though I'm wary that eventual lowering interest rates may make annuities seem a little less appealing to retirees if they lead to lower payment rates.

The broker believes the FY24 result "went a long way to addressing market concerns for life margins, capital and business quality". Cost control was a "key feature", and it sees "further earnings upside from this source".

UBS suggested that Challenger's guidance appears to be conservative, with the broker forecasting a net profit before tax of $695 million. Challenger's guidance for normalised NPBT is between $640 million and $700 million.

The broker rates Challenger shares as a buy and increased its price target to $8.30. That implies a possible rise of around 13% from today's level.

Challenger is guiding normalised net profit after tax will be between $440 million to $480 million. UBS is forecasting NPAT of $487 million in FY25 and $561 million in FY26.

The broker is also suggesting the annual dividend per share could rise to 31 cents per share in FY25 and 35 cents per share in FY26. The FY25 dividend could translate into a grossed-up dividend yield of around 6%.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Challenger. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Financial Shares

young woman reviewing financial reports at desk with multiple computer screens
Opinions

Brokers' verdict on 4 popular ASX 200 financial stocks

Financials outperformed every other sector in FY25. What should you do now with these 4 stocks?

Read more »

a man in a business suit sits at his laptop computer at his desk and smiles broadly in an office setting, giving an air of optimism and confidence.
Dividend Investing

Up 25% since April, are Macquarie shares still a good buy for passive income?

A leading expert gives his verdict on Macquarie shares and the passive income on offer.

Read more »

A green-caped superhero reveals their identity with a big dollar sign on their chest.
Financial Shares

Own Soul Patts shares? Here's its latest investment for diversification

The company has added further energy exposure to its portfolio.

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
Financial Shares

2 rising ASX financial shares with 'meaningful upside' still left: fundie

Financials outperformed every other sector in FY25, but there are still buying opportunities left, say these experts.

Read more »

Frustrated and shocked business woman reading bad news online from phone.
Financial Shares

Macquarie shares sink 5% on Q1 update

The investment bank is having a tough start to the year.

Read more »

A man holds his baby on his lap at the dining room table while he looks at his laptop screen earnestly.
Financial Shares

After its result, does Macquarie rate AMP shares a buy, hold or sell?

The financial services company released a strong second-quarter update on Monday.

Read more »

A blockchain investor sits at his desk with a laptop computer open and a phone checking information from a booklet in a home office setting.
Broker Notes

Are non-bank lenders a lucrative alternative to the big 4 banks?

The big 4 banks are widely perceived as being fully valued or overvalued.

Read more »

Red sell button on an Apple keyboard.
Financial Shares

ASX 200 financials was the best sector of FY25. But it's time to sell these 2 stocks, say experts

The ASX 200 financials sector gave investors a near-30% total return in the 2025 financial year.

Read more »